FDA Clearance Tracker · P970003-S211
VNS Therapy Model 3000 Programmer
Last checked: Nov 20, 2026Latest source record: Oct 3, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Oct 3, 2017
Approved
Time to decision
154 days
Received May 2, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970003-S211
- Device name
- VNS Therapy Model 3000 Programmer
- Applicant
- LivaNova USA, Inc.
- Applicant location
- Houston, TX
- Received
- May 2, 2017
- Decided
- Oct 3, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P970003
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the introduction of the Model3000 Programmer into interstate commerce.
Source documents
Other decisions for LivaNova USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250013 · Decided Mar 18, 2026 · 327 days after receipt
Device type: Stimulator, hypoglossal nerve, implanted, apnea (MNQ) · Anesthesiology & Respiratory
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.